One Prediction For US FDA Under Biden: More Advisory Committees

 
• By Michael McCaughan
  
Rostrum with microphone and computer in conference hall
Could the US FDA return to in-person advisory committees this year?

More from US FDA Performance Tracker

More from Regulatory Trackers